CXCR1 and colorectal cancer: The inhibition of CXCR1/2 limits neutrophil infiltration and results in the decreased growth of multiple tumors, including lung adenocarcinoma (70), colorectal cancer (71), and pancreatic ductal adenocarcinoma (72).